HroMed-X Corp.

HroMed-X Corp. Solving the mental health crisis one trip at a time. Innovating and bioengineering fungi, taking down pharmaceutical pill pushing cartels.

06/25/2026

HroMed-X Update: Psilazolam Successfully Synthesized

We are thrilled to announce that HroMed-X has successfully manufactured the first batch of Psilazolam, our patent-pending flagship novel psychedelic compound.

This milestone validates our unique hybrid molecule and marks a major step toward next-generation mental health treatments. Mass production is scheduled to ramp up in late 2027 through 2028 in Jamaica, supported by ongoing cultivation, research, and retreat programs.

Stay tuned for further updates as we advance toward clinical data and commercial availability.

Thank you to our supporters who made this possible. The medical revolution is moving faster than expected.

— Tristan Hrominchuk, Founder & CEO
HroMed-X Psychedelic Pharmaceuticals

https://pmc.ncbi.nlm.nih.gov/articles/PMC9577917/
06/11/2026

https://pmc.ncbi.nlm.nih.gov/articles/PMC9577917/

Alcohol use disorder is a difficult-to-treat psychiatric disorder and a major burden on public health. Existing treatment efficacy is moderate, and relapse rates are high. Preliminary findings suggest that psilocybin, a psychedelic compound, can ...

https://gofund.me/d535a73f3
06/09/2026

https://gofund.me/d535a73f3

Our Story: HroMed-X Corp. Was born from a deep personal con… Tristan Hrominchuk needs your support for Solve The Mental Health Crisis Through New Research

Address

Box 524
Dauphin, MB
R7N2V3

Website

Alerts

Be the first to know and let us send you an email when HroMed-X Corp. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category